Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The annual Global Young Scientists Summit (GYSS) took place virtually on 12–15 January 2021. The GYSS was started in 2013 with the objective of exciting and engaging young scientists to pursue their scientific dreams through close interactions with distinguished scientists and researchers, and with peers. Each year, about 280 international young scientists discuss key areas of science and research, technology innovation and society, and potential solutions to global challenges. The summit is multi-disciplinary, covering topics relevant to chemistry, physics, medicine, mathematics, computer science and engineering. Invited speakers are globally recognised scientific leaders, including recipients of the Nobel Prize, Fields Medal, Millennium Technology Prize, and the Turing Award. 

The Department's Arussa Nawaz (Blagden Group) and Hannah Bolland (Hammond Group) were both invited by the University to attend this prestigious event as part of a selected Oxford contingent. 

'The GYSS conference was a great start to the year, being exposed to young and senior scientists from different disciplines all over the world. The difficulty was the time zone with the conference being held at Singapore time, but the organisers uploaded all of the talks online allowing me to catch up after my day in the lab.' - Arussa 


Participants were able to take part in live plenary lectures, panel discussions and Q&A sessions, as well as participate in a small group informal session with their pre-selected speaker and interact with other attendees during the networking sessions.
 

'One of the highlights of the event was the informal 1-1 session with Nobel Prize laureate Sir Peter Ratcliffe who gave wonderful insights on his own career as well as advice on our own career choices. I also enjoyed listening to Rob Langer discuss his research career from post-doc to now having the largest biomedical engineering lab in the world at MIT and is also one of the founders of Moderna - whom as we know are pioneering one of the COVID-19 vaccines.

'The conference left me feeling motivated and determined despite the challenges our current situation brings us! Hopefully next year I will be able to attend in person and meet more members, face-to-face in happier and safer times.' - Arussa

Congratulations to Arussa and Hannah  for being selected to attend this summit. Details of the next summit, as well as how to put yourself forward for consideration to join the Oxford contingent, will be published later on in the year.

 

Similar stories

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

Robert Watson Awarded ACP McElwain and Presidents Prize

Dr Robert Watson has won one of three McElwain and President's Prizes from the Association of Cancer Physicians for his DPhil work undertaken with Professor Ben Fairfax.

Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.

SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.

Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre

Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.

Machine Learning Predicts SETD2 Mutation Status with Unprecedented Accuracy using DNA methylation

In a pan-cancer analysis spanning 24 different cancer type, researchers shed light on the critical role of SETD2 in tumourigenesis.

Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies

Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.